Infliximab and adalimumab, unlike ustekinumab, increase serum KL-6 levels in Japanese patients with psoriasis

Title
Infliximab and adalimumab, unlike ustekinumab, increase serum KL-6 levels in Japanese patients with psoriasis
Authors
Keywords
-
Journal
JOURNAL OF DERMATOLOGY
Volume 42, Issue 8, Pages 828-829
Publisher
Wiley
Online
2015-04-28
DOI
10.1111/1346-8138.12918

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started